36 Companies
Companies in Psychedelic Medicine
From public biotech advancing clinical trials to service centers providing legal access, explore the companies shaping the future of psychedelic therapy.
Johns Hopkins University
39
Trials
0
Open Roles
COMPASS Pathways
CMPS8
Trials
80
Open Roles
Delix Therapeutics
0
Trials
0
Open Roles
Mount Sinai
15
Trials
0
Open Roles
MAPS
3
Trials
0
Open Roles
AtaiBeckley
ATAI3
Trials
0
Open Roles
UC Berkeley
0
Trials
0
Open Roles
Columbia University
4
Trials
0
Open Roles
Ceruvia Lifesciences
0
Trials
0
Open Roles
Lykos Therapeutics
3
Trials
0
Open Roles
Yale University
58
Trials
0
Open Roles
Headlands Research
0
Trials
58
Open Roles
Definium Therapeutics
DFTX4
Trials
12
Open Roles
Clerkenwell Health
0
Trials
0
Open Roles
Mindstate Design Labs
0
Trials
0
Open Roles
DemeRx
0
Trials
0
Open Roles
Enveric Biosciences
0
Trials
0
Open Roles
Emory University
8
Trials
0
Open Roles
Usona Institute
5
Trials
0
Open Roles
Helus Pharma
HELP6
Trials
0
Open Roles
GH Research
GHRS9
Trials
0
Open Roles
University of Colorado
8
Trials
0
Open Roles
Ohio State University
2
Trials
0
Open Roles
University of New Mexico
9
Trials
0
Open Roles
CaaMTech
0
Trials
0
Open Roles
Filament Health
FH0
Trials
0
Open Roles
Wavepaths
0
Trials
0
Open Roles
Stanford University
14
Trials
0
Open Roles
UCSF Translational Psychedelic Research
0
Trials
0
Open Roles
Sunstone Therapies
0
Trials
0
Open Roles
All Points North
0
Trials
0
Open Roles
Portland Psychotherapy Clinic
0
Trials
0
Open Roles
NYU Langone Center for Psychedelic Medicine
0
Trials
0
Open Roles
University of Pennsylvania
4
Trials
0
Open Roles
Naropa University
0
Trials
0
Open Roles
Fluence
0
Trials
0
Open Roles